title: Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.
abstract: Infection with dengue virus is a major public health problem in the Asia-Pacific region and throughout tropical and sub-tropical regions of the world. Vaccination represents a major opportunity to control dengue and several candidate vaccines are in development. Experts in dengue and in vaccine introduction gathered for a two day meeting during which they examined the challenges inherent to the introduction of a dengue vaccine into the national immunisation programmes of countries of the Asia-Pacific. The aim was to develop a series of recommendations to reduce the delay between vaccine licensure and vaccine introduction. Major recommendations arising from the meeting included: ascertaining and publicising the full burden and cost of dengue; changing the perception of dengue in non-endemic countries to help generate global support for dengue vaccination; ensuring high quality active surveillance systems and diagnostics; and identifying sustainable sources of funding, both to support vaccine introduction and to maintain the vaccination programme. The attendees at the meeting were in agreement that with the introduction of an effective vaccine, dengue is a disease that could be controlled, and that in order to ensure a vaccine is introduced as rapidly as possible, there is a need to start preparing now.
authors.affiliation: Office of the Vice-Chancellor, University of Malaya, Jalan Pantai Baru, 50603 Kuala Lumpur, Malaysia. sklam@nipahvirus.org
authors.forename: Sai Kit
authors.initials: SK
authors.lastname: Lam
authors.forename: Donald
authors.initials: D
authors.lastname: Burke
authors.forename: Maria Rosario
authors.initials: MR
authors.lastname: Capeding
authors.forename: Chee Keong
authors.initials: CK
authors.lastname: Chong
authors.forename: Laurent
authors.initials: L
authors.lastname: Coudeville
authors.forename: Jeremy
authors.initials: J
authors.lastname: Farrar
authors.forename: Duane
authors.initials: D
authors.lastname: Gubler
authors.forename: Sri Rezeki
authors.initials: SR
authors.lastname: Hadinegoro
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Hanna
authors.forename: Jean
authors.initials: J
authors.lastname: Lang
authors.forename: Han Lim
authors.initials: HL
authors.lastname: Lee
authors.forename: Yee Sin
authors.initials: YS
authors.lastname: Leo
authors.forename: Chan Quang
authors.initials: CQ
authors.lastname: Luong
authors.forename: Richard
authors.initials: R
authors.lastname: Mahoney
authors.forename: John
authors.initials: J
authors.lastname: McBride
authors.forename: Jorge
authors.initials: J
authors.lastname: Mendez-Galvan
authors.forename: Lee Ching
authors.initials: LC
authors.lastname: Ng
authors.forename: Suchitra
authors.initials: S
authors.lastname: Nimmannitya
authors.forename: Eng Eong
authors.initials: EE
authors.lastname: Ooi
authors.forename: Donald
authors.initials: D
authors.lastname: Shepard
authors.forename: Jaco
authors.initials: J
authors.lastname: Smit
authors.forename: Rémy
authors.initials: R
authors.lastname: Teyssou
authors.forename: Laurent
authors.initials: L
authors.lastname: Thomas
authors.forename: Joseph
authors.initials: J
authors.lastname: Torresi
authors.forename: Pedro
authors.initials: P
authors.lastname: Vasconcelos
authors.forename: Dewa Nyoman
authors.initials: DN
authors.lastname: Wirawan
authors.forename: Sutee
authors.initials: S
authors.lastname: Yoksan
mesh_terms: D001208:Asia; D003226:Congresses as Topic; D003715:Dengue / Q000188:drug therapy / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000008:administration & dosage*; D003716:Dengue Virus / Q000276:immunology; D006287:Health Planning Guidelines; D006801:Humans; D017589:Immunization Programs / Q000191:economics; D011634:Public Health; D014611:Vaccination
chemical_list: D053059:Dengue Vaccines